Clinical Trials in Austin

Showing 2441-2460 of 15,205 trials

Activating the Cholinergic Anti-Inflammatory Pathway in Healthy Volunteers and People With Inflammatory Arthritis

NCT06555562

This study is designed to investigate whether non-invasive ultrasound (US) that is optimized for stimulation and can elicit an anti-inflammatory response in people with Inflammatory Arthritis as compared to a sham intervention. The primary endpoint is the change in pro-inflammatory cytokines in blood drawn before and after US. Each participant receives 4 experimental US sessions, one of which is randomly assigned to be placebo.

Psoriatic ArthritisRheumatoid ArthritisAnkylosing Spondylitis

Surf Therapeutics16 participantsStarted Oct 2025

Austin, Texas, United States • Houston, Texas, United States

Active Not RecruitingPhase 2< 1 mile

A Study of CT-388 in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus

NCT06628362

This is a multi-center, randomized, double-blind, placebo-controlled, parallel group dose-finding study to evaluate the efficacy and safety of CT-388 at low, middle, and high doses in participants who are overweight or obese with Type 2 diabetes mellitus (T2DM).

Overweight or ObeseType 2 Diabetes Mellitus (T2DM)

Carmot Therapeutics, Inc.360 participantsStarted Nov 2024

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Guntersville, Alabama, United States +67 more locations

Activating the Cholinergic Anti-Inflammatory Pathway in Healthy Volunteers and People With Inflammatory Arthritis

A Study of CT-388 in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus

Find Trials by Condition in Austin

A Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment

Abbott DBS Post-Market Study of Outcomes for Indications Over Time

A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With Hyperphosphatemia

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GS-9716 as Monotherapy and in Combination With Anticancer Therapies in Adults With Solid Malignancies

Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic Atrophy

RESTORE: REducing Future fractureS and Improving ouTcOmes of fRagility fracturE

Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia

Shoulder iD™ Primary Reversed Glenoid Outcomes Clinical Study

Efficacy of Placental Membrane Dressings in Accelerating Diabetic Foot Healing

Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial)

A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With Systemic Lupus Erythematosus

A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)

Study of Bitopertin to Evaluate the Safety, Tolerability, Efficacy, and PPIX Concentrations in Participants With EPP

Investigation of the Two Level Simplify® Cervical Artificial Disc

Post Approval Study Protocol for the Two Level Simplify® Cervical Artificial Disc

A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors

Hearing Outcomes With the Osia 3 Sound Processor Compared to the Osia 2 Sound Processor in Adult Osia Implant Recipients

Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab.